logo

For the Inventor, By the Inventor

Urawa, Japan

Hiroshi Narita

This inventor holds 9 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1992-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Narita. Retrieved from https://idiyas.com/inventor/hiroshi-narita-c8do0lb6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:

goldMedal9 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1992-1998

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5753672 - Imidazopyridine derivatives and process for preparing the same (1998-05-19),
2. 5637582 - Peripheral circulation improving agent (1997-06-10),
3. 5510354 - Imidazopyridine derivatives (1996-04-23),
4. 5424316 - Imidazopyridine derivatives for the treatment of hypertension (1995-06-13),
5. 5409936 - Imidazopyridine derivatives for the treatment of hypertension (1995-04-25),
6. 5387581 - Pharmaceutical composition of aspirin and a benzothiazepine for (1995-02-07),
7. 5382577 - Pharmaceutical composition for inhibiting platelet aggregation (1995-01-17),
8. 5268377 - Imidazoindolizine derivatives process for preparation thereof and use (1993-12-07),
9. 5134139 - 1,5-benzothiazepine derivatives and preparation thereof (1992-07-28),

Title: Hiroshi Narita: Innovator in Pharmaceutical Chemistry

Introduction

Hiroshi Narita is a prominent inventor based in Urawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. His work focuses on developing innovative compounds that have therapeutic applications.

Latest Patents

Among his latest patents is the invention of imidazopyridine derivatives, which are characterized by their excellent angiotensin II antagonistic activity. These derivatives are useful for the prophylaxis or treatment of hypertension. Another notable patent involves a peripheral circulation improving agent, specifically a (-)-cis-1,5-benzothiazepine, which serves as a prophylactic and/or curing agent for Raynaud's disease and chronic arterial obstruction.

Career Highlights

Hiroshi Narita is currently associated with Tanabe Seiyaku Company, Limited, where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Narita has collaborated with esteemed colleagues, including Yasuo Sekine and Yasushi Honma. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Hiroshi Narita's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field positively, paving the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…